{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:46:36Z","timestamp":1790480796301,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870949"],"award-info":[{"award-number":["81870949"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Gansu province","award":["21JR7RA452"],"award-info":[{"award-number":["21JR7RA452"]}]},{"name":"Lanzhou University Medical Research Innovation Capacity Enhancement Program","award":["lzuyxcx-2022-179"],"award-info":[{"award-number":["lzuyxcx-2022-179"]}]},{"name":"Gansu Provincial Joint Funds","award":["24JRRA817"],"award-info":[{"award-number":["24JRRA817"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02454-4","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:17:08Z","timestamp":1786353428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Botulinum toxin type A attenuates trigeminal neuralgia-like pain by suppressing CGRP release and modulating NaV1.7-associated signaling"],"prefix":"10.1186","volume":"27","author":[{"given":"Min-Hua","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Rui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hong","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"2454_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","volume":"160","author":"J Scholz","year":"2019","unstructured":"Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI et al (2019) The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain 160:53\u201359","journal-title":"Pain"},{"key":"2454_CR2","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S1474-4422(20)30233-7","volume":"19","author":"L Bendtsen","year":"2020","unstructured":"Bendtsen L, Zakrzewska JM, Heinskou TB, Hodaie M, Leal PRL, Nurmikko T et al (2020) Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol 19:784\u2013796","journal-title":"Lancet Neurol"},{"key":"2454_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1056\/NEJMra1914484","volume":"383","author":"G Cruccu","year":"2020","unstructured":"Cruccu G, Di Stefano G, Truini A (2020) Trigeminal Neuralgia. N Engl J Med 383:754\u2013762","journal-title":"N Engl J Med"},{"key":"2454_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41572-024-00523-z","volume":"10","author":"S Ashina","year":"2024","unstructured":"Ashina S, Robertson CE, Srikiatkhachorn A, Di Stefano G, Donnet A, Hodaie M et al (2024) Trigeminal neuralgia. Nat Rev Dis Primers 10:39","journal-title":"Nat Rev Dis Primers"},{"key":"2454_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jpain.2023.08.012","volume":"25","author":"SH Mousavi","year":"2024","unstructured":"Mousavi SH, Lindsey JW, Westlund KN, Alles SRA (2024) Trigeminal Neuralgia as a Primary Demyelinating Disease: Potential Multimodal Evidence and Remaining Controversies. J Pain 25:302\u2013311","journal-title":"J Pain"},{"key":"2454_CR6","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3171\/jns.2002.96.3.0532","volume":"96","author":"M Devor","year":"2002","unstructured":"Devor M, Govrin-Lippmann R, Rappaport ZH (2002) Mechanism of trigeminal neuralgia: an ultrastructural analysis of trigeminal root specimens obtained during microvascular decompression surgery. J Neurosurg 96:532\u2013543","journal-title":"J Neurosurg"},{"key":"2454_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/ene.13950","volume":"26","author":"L Bendtsen","year":"2019","unstructured":"Bendtsen L, Zakrzewska JM, Abbott J, Braschinsky M, Di Stefano G, Donnet A et al (2019) European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol 26:831\u2013849","journal-title":"Eur J Neurol"},{"key":"2454_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.expneurol.2006.05.035","volume":"202","author":"SL Davies","year":"2006","unstructured":"Davies SL, Loescher AR, Clayton NM, Bountra C, Robinson PP, Boissonade FM (2006) Changes in sodium channel expression following trigeminal nerve injury. Exp Neurol 202:207\u2013216","journal-title":"Exp Neurol"},{"key":"2454_CR9","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.ynpai.2022.100084","volume":"11","author":"Y Mulpuri","year":"2022","unstructured":"Mulpuri Y, Yamamoto T, Nishimura I, Spigelman I (2022) Role of voltage-gated sodium channels in axonal signal propagation of trigeminal ganglion neurons after infraorbital nerve entrapment. Neurobiol Pain 11:100084","journal-title":"Neurobiol Pain"},{"key":"2454_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.neuroscience.2009.08.037","volume":"164","author":"SR Siqueira","year":"2009","unstructured":"Siqueira SR, Alves B, Malpartida HM, Teixeira MJ, Siqueira JT (2009) Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia. Neuroscience 164:573\u2013577","journal-title":"Neuroscience"},{"key":"2454_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/WNR.0000000000000632","volume":"27","author":"W Xu","year":"2016","unstructured":"Xu W, Zhang J, Wang Y, Wang L, Wang X (2016) Changes in the expression of voltage-gated sodium channels Nav1.3, Nav1.7, Nav1.8, and Nav1.9 in rat trigeminal ganglia following chronic constriction injury. NeuroReport 27:929\u2013934","journal-title":"NeuroReport"},{"key":"2454_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa2209870","volume":"389","author":"J Jones","year":"2023","unstructured":"Jones J, Correll DJ, Lechner SM, Jazic I, Miao X, Shaw D et al (2023) Selective Inhibition of Na(V)1.8 with VX-548 for Acute Pain. N Engl J Med 389:393\u2013405","journal-title":"N Engl J Med"},{"key":"2454_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-024-01108-x","volume":"24","author":"M Alsaloum","year":"2025","unstructured":"Alsaloum M, Dib-Hajj SD, Page DA, Ruben PC, Krainer AR, Waxman SG (2025) Voltage-gated sodium channels in excitable cells as drug targets. Nat Rev Drug Discov 24:358\u2013378","journal-title":"Nat Rev Drug Discov"},{"key":"2454_CR14","doi-asserted-by":"publisher","first-page":"E1670","DOI":"10.1002\/humu.21325","volume":"31","author":"JJ Cox","year":"2010","unstructured":"Cox JJ, Sheynin J, Shorer Z, Reimann F, Nicholas AK, Zubovic L et al (2010) Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Hum Mutat 31:E1670\u2013E1686","journal-title":"Hum Mutat"},{"key":"2454_CR15","doi-asserted-by":"publisher","first-page":"10180","DOI":"10.1523\/JNEUROSCI.1049-18.2018","volume":"38","author":"SD Shields","year":"2018","unstructured":"Shields SD, Deng L, Reese RM, Dourado M, Tao J, Foreman O et al (2018) Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors. J Neurosci 38:10180\u201310201","journal-title":"J Neurosci"},{"key":"2454_CR16","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.neuron.2021.03.012","volume":"109","author":"DI MacDonald","year":"2021","unstructured":"MacDonald DI, Sikandar S, Weiss J, Pyrski M, Luiz AP, Millet Q et al (2021) A central mechanism of analgesia in mice and humans lacking the sodium channel Na(V)1.7. Neuron 109:1497\u2013512e6","journal-title":"Neuron"},{"key":"2454_CR17","doi-asserted-by":"publisher","first-page":"8967","DOI":"10.1038\/ncomms9967","volume":"6","author":"MS Minett","year":"2015","unstructured":"Minett MS, Pereira V, Sikandar S, Matsuyama A, Lolignier S, Kanellopoulos AH et al (2015) Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7. Nat Commun 6:8967","journal-title":"Nat Commun"},{"key":"2454_CR18","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1111\/bph.15327","volume":"179","author":"DA Eagles","year":"2022","unstructured":"Eagles DA, Chow CY, King GF (2022) Fifteen years of Na(V) 1.7 channels as an analgesic target: Why has excellent in vitro pharmacology not translated into in vivo analgesic efficacy? Br J Pharmacol 179:3592\u20133611","journal-title":"Br J Pharmacol"},{"key":"2454_CR19","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/j.pain.0000000000001227","volume":"159","author":"A McDonnell","year":"2018","unstructured":"McDonnell A, Collins S, Ali Z, Iavarone L, Surujbally R, Kirby S et al (2018) Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy. Pain 159:1465\u20131476","journal-title":"Pain"},{"key":"2454_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1474-4422(17)30005-4","volume":"16","author":"JM Zakrzewska","year":"2017","unstructured":"Zakrzewska JM, Palmer J, Morisset V, Giblin GM, Obermann M, Ettlin DA et al (2017) Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol 16:291\u2013300","journal-title":"Lancet Neurol"},{"key":"2454_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0196-9781(91)90022-H","volume":"12","author":"U Pedersen-Bjergaard","year":"1991","unstructured":"Pedersen-Bjergaard U, Nielsen LB, Jensen K, Edvinsson L, Jansen I, Olesen J (1991) Calcitonin gene-related peptide, neurokinin A and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides 12:333\u2013337","journal-title":"Peptides"},{"key":"2454_CR22","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(25)00109-6","volume":"405","author":"J Versijpt","year":"2025","unstructured":"Versijpt J, Paemeleire K, Reuter U, MaassenVanDenBrink A (2025) Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives. Lancet 405:1014\u20131026","journal-title":"Lancet"},{"key":"2454_CR23","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","volume":"103","author":"AF Russo","year":"2023","unstructured":"Russo AF, Hay DL (2023) CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev 103:1565\u20131644","journal-title":"Physiol Rev"},{"key":"2454_CR24","doi-asserted-by":"crossref","unstructured":"Afroz S, Arakaki R, Iwasa T, Oshima M, Hosoki M, Inoue M et al (2019) CGRP induces differential regulation of cytokines from satellite glial cells in trigeminal ganglia and orofacial nociception. Int J Mol Sci 20","DOI":"10.3390\/ijms20030711"},{"key":"2454_CR25","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1523\/JNEUROSCI.4872-09.2010","volume":"30","author":"S Stamboulian","year":"2010","unstructured":"Stamboulian S, Choi JS, Ahn HS, Chang YW, Tyrrell L, Black JA et al (2010) ERK1\/2 mitogen-activated protein kinase phosphorylates sodium channel Na(v)1.7 and alters its gating properties. J Neurosci 30:1637\u20131647","journal-title":"J Neurosci"},{"key":"2454_CR26","doi-asserted-by":"publisher","first-page":"12309","DOI":"10.1073\/pnas.1706656114","volume":"114","author":"RE Yarwood","year":"2017","unstructured":"Yarwood RE, Imlach WL, Lieu T, Veldhuis NA, Jensen DD, Klein Herenbrink C et al (2017) Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission. Proc Natl Acad Sci U S A 114:12309\u201312314","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2454_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ana.21427","volume":"64","author":"D Ranoux","year":"2008","unstructured":"Ranoux D, Attal N, Morain F, Bouhassira D (2008) Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 64:274\u2013283","journal-title":"Ann Neurol"},{"key":"2454_CR28","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1212\/01.wnl.0000180940.98815.74","volume":"65","author":"EJ Piovesan","year":"2005","unstructured":"Piovesan EJ, Teive HG, Kowacs PA, Della Coletta MV, Werneck LC, Silberstein SD (2005) An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology 65:1306\u20131308","journal-title":"Neurology"},{"key":"2454_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1129-2377-14-92","volume":"14","author":"HS Shehata","year":"2013","unstructured":"Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G (2013) Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? J Headache Pain 14:92","journal-title":"J Headache Pain"},{"key":"2454_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1129-2377-14-72","volume":"14","author":"Y Hu","year":"2013","unstructured":"Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z et al (2013) Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review. J Headache Pain 14:72","journal-title":"J Headache Pain"},{"key":"2454_CR31","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/pm\/pnaa028","volume":"21","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Lian Y, Zhang H, Xie N, Chen Y (2020) CGRP Plasma Levels Decrease in Classical Trigeminal Neuralgia Patients Treated with Botulinum Toxin Type A: A Pilot Study. Pain Med 21:1611\u20131615","journal-title":"Pain Med"},{"key":"2454_CR32","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1523\/JNEUROSCI.5490-08.2009","volume":"29","author":"J Meng","year":"2009","unstructured":"Meng J, Ovsepian SV, Wang J, Pickering M, Sasse A, Aoki KR et al (2009) Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. J Neurosci 29:4981\u20134992","journal-title":"J Neurosci"},{"key":"2454_CR33","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.pain.2011.04.033","volume":"152","author":"Q Hou","year":"2011","unstructured":"Hou Q, Barr T, Gee L, Vickers J, Wymer J, Borsani E et al (2011) Keratinocyte expression of calcitonin gene-related peptide \u03b2: implications for neuropathic and inflammatory pain mechanisms. Pain 152:2036\u20132051","journal-title":"Pain"},{"key":"2454_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/head.14726","volume":"64","author":"PV Reducha","year":"2024","unstructured":"Reducha PV, B\u00f6mers JP, Edvinsson L, Haanes KA (2024) The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model. Headache 64:652\u2013662","journal-title":"Headache"},{"key":"2454_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s40064-016-2071-2","volume":"5","author":"C Wu","year":"2016","unstructured":"Wu C, Xie N, Lian Y, Xu H, Chen C, Zheng Y et al (2016) Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia. Springerplus 5:431","journal-title":"Springerplus"},{"key":"2454_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00002508-200201000-00002","volume":"18","author":"M Devor","year":"2002","unstructured":"Devor M, Amir R, Rappaport ZH (2002) Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 18:4\u201313","journal-title":"Clin J Pain"},{"key":"2454_CR37","doi-asserted-by":"publisher","first-page":"1026e1","DOI":"10.1016\/j.joms.2020.12.041","volume":"79","author":"AE Boyke","year":"2021","unstructured":"Boyke AE, Naidu I, Lam S, Alvi MA, Bader ER, Agarwal V (2021) Medical Malpractice and Trigeminal Neuralgia: An Analysis of 49 Cases. J Oral Maxillofac Surg 79:1026e1\u2013e8","journal-title":"J Oral Maxillofac Surg"},{"key":"2454_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","volume":"56","author":"HZ Rappaport","year":"1994","unstructured":"Rappaport HZ, Devor M (1994) Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion. Pain 56:127\u2013138","journal-title":"Pain"},{"key":"2454_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.410330202","volume":"33","author":"SG Waxman","year":"1993","unstructured":"Waxman SG, Ritchie JM (1993) Molecular dissection of the myelinated axon. Ann Neurol 33:121\u2013136","journal-title":"Ann Neurol"},{"key":"2454_CR40","doi-asserted-by":"publisher","first-page":"8881","DOI":"10.1523\/JNEUROSCI.23-26-08881.2003","volume":"23","author":"BC Hains","year":"2003","unstructured":"Hains BC, Klein JP, Saab CY, Craner MJ, Black JA, Waxman SG (2003) Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J Neurosci 23:8881\u20138892","journal-title":"J Neurosci"},{"key":"2454_CR41","first-page":"182","volume":"68","author":"ZH Rappaport","year":"1997","unstructured":"Rappaport ZH, Govrin-Lippmann R, Devor M (1997) An electron-microscopic analysis of biopsy samples of the trigeminal root taken during microvascular decompressive surgery. Stereotact Funct Neurosurg 68:182\u2013186","journal-title":"Stereotact Funct Neurosurg"},{"key":"2454_CR42","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.1523\/JNEUROSCI.0547-21.2021","volume":"41","author":"JB Pineda-Farias","year":"2021","unstructured":"Pineda-Farias JB, Loeza-Alcocer E, Nagarajan V, Gold MS, Sekula RF (2021) Jr. Mechanisms Underlying the Selective Therapeutic Efficacy of Carbamazepine for Attenuation of Trigeminal Nerve Injury Pain. J Neurosci 41:8991\u20139007","journal-title":"J Neurosci"},{"key":"2454_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/365160a0","volume":"365","author":"J Blasi","year":"1993","unstructured":"Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P et al (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160\u2013163","journal-title":"Nature"},{"key":"2454_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","volume":"186","author":"I Matak","year":"2011","unstructured":"Matak I, Bach-Rojecky L, Filipovi\u0107 B, Lackovi\u0107 Z (2011) Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience 186:201\u2013207","journal-title":"Neuroscience"},{"key":"2454_CR45","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1242\/jcs.012211","volume":"120","author":"J Meng","year":"2007","unstructured":"Meng J, Wang J, Lawrence G, Dolly JO (2007) Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential. J Cell Sci 120:2864\u20132874","journal-title":"J Cell Sci"},{"key":"2454_CR46","doi-asserted-by":"publisher","first-page":"333102422114168","DOI":"10.1177\/03331024221141683","volume":"43","author":"AA Moore","year":"2023","unstructured":"Moore AA, Nelson M, Wickware C, Choi S, Moon G, Xiong E et al (2023) OnabotulinumtoxinA effects on trigeminal nociceptors. Cephalalgia 43:3331024221141683","journal-title":"Cephalalgia"},{"key":"2454_CR47","doi-asserted-by":"publisher","first-page":"21226","DOI":"10.1038\/srep21226","volume":"6","author":"J Meng","year":"2016","unstructured":"Meng J, Wang J, Steinhoff M, Dolly JO (2016) TNF\u03b1 induces co-trafficking of TRPV1\/TRPA1 in VAMP1-containing vesicles to the plasmalemma via Munc18-1\/syntaxin1\/SNAP-25 mediated fusion. Sci Rep 6:21226","journal-title":"Sci Rep"},{"key":"2454_CR48","doi-asserted-by":"crossref","unstructured":"Belinskaia M, Zurawski T, Kaza SK, Antoniazzi C, Dolly JO, Lawrence GW (2022) NGF enhances CGRP release evoked by capsaicin from rat trigeminal neurons: differential inhibition by SNAP-25-cleaving proteases. Int J Mol Sci 23","DOI":"10.3390\/ijms23020892"},{"key":"2454_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s10194-024-01769-4","volume":"25","author":"G G\u00e1rate","year":"2024","unstructured":"G\u00e1rate G, Pascual J, Pascual-Mato M, Madera J, Mart\u00edn MM, Gonz\u00e1lez-Quintanilla V (2024) Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience. J Headache Pain 25:69","journal-title":"J Headache Pain"},{"key":"2454_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JPR.S432031","volume":"17","author":"MK Rahardian","year":"2024","unstructured":"Rahardian MK, Putri FA, Maulina T (2024) Association Between Orofacial Pain and Anxiety: A Systematic Review. J Pain Res 17:1\u201310","journal-title":"J Pain Res"},{"key":"2454_CR51","doi-asserted-by":"publisher","unstructured":"LianX, Xie T, Chen C, Deng J, Zhao S, Gao T et al (2026) A modified FLIT-B model of trigeminal neuralgia reveals anterior cingulate cortex involvement in anxiety-like behavior in mice. J Headache Pain. https:\/\/doi.org\/10.1186\/s10194-026-02394-z","DOI":"10.1186\/s10194-026-02394-z"},{"key":"2454_CR52","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1177\/0022034516659278","volume":"95","author":"KY Yang","year":"2016","unstructured":"Yang KY, Kim MJ, Ju JS, Park SK, Lee CG, Kim ST et al (2016) Antinociceptive Effects of Botulinum Toxin Type A on Trigeminal Neuropathic Pain. J Dent Res 95:1183\u20131190","journal-title":"J Dent Res"},{"key":"2454_CR53","doi-asserted-by":"publisher","first-page":"109967","DOI":"10.1016\/j.neuropharm.2024.109967","volume":"253","author":"AB Kesdo\u011fan","year":"2024","unstructured":"Kesdo\u011fan AB, Neureiter A, Gaebler AJ, Kalia AK, K\u00f6rner J, Lampert A (2024) Analgesic effect of Botulinum toxin in neuropathic pain is sodium channel independent. Neuropharmacology 253:109967","journal-title":"Neuropharmacology"},{"key":"2454_CR54","doi-asserted-by":"publisher","first-page":"7909","DOI":"10.1523\/JNEUROSCI.21-20-07909.2001","volume":"21","author":"K Vijayaragavan","year":"2001","unstructured":"Vijayaragavan K, O\u2019Leary ME, Chahine M (2001) Gating properties of Na(v)1.7 and Na(v)1.8 peripheral nerve sodium channels. J Neurosci 21:7909\u20137918","journal-title":"J Neurosci"},{"key":"2454_CR55","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn3404","volume":"14","author":"SD Dib-Hajj","year":"2013","unstructured":"Dib-Hajj SD, Yang Y, Black JA, Waxman SG (2013) The Na(V)1.7 sodium channel: from molecule to man. Nat Rev Neurosci 14:49\u201362","journal-title":"Nat Rev Neurosci"},{"key":"2454_CR56","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.ynpai.2024.100168","volume":"16","author":"F Iseppon","year":"2024","unstructured":"Iseppon F, Kanellopoulos AH, Tian N, Zhou J, Caan G, Chiozzi R et al (2024) Sodium channels Na(v)1.7, Na(v)1.8 and pain; two distinct mechanisms for Na(v)1.7 null analgesia. Neurobiol Pain 16:100168","journal-title":"Neurobiol Pain"},{"key":"2454_CR57","doi-asserted-by":"publisher","first-page":"137806","DOI":"10.1016\/j.neulet.2024.137806","volume":"832","author":"X Li","year":"2024","unstructured":"Li X, Liu Y, Shao M, Wang J, Wang L, Wang Y et al (2024) Exploring the mechanism of Nav1.3 in the ION-CCI rat model based on the TLR4\/TRAF6\/NF-\u03baB pathway. Neurosci Lett 832:137806","journal-title":"Neurosci Lett"},{"key":"2454_CR58","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/j.pain.0000000000003394","volume":"166","author":"X Zhang","year":"2025","unstructured":"Zhang X, Hartung JE, Gold MS (2025) Persistent (Na v 1.9) sodium currents in human dorsal root ganglion neurons. Pain 166:448\u2013459","journal-title":"Pain"},{"key":"2454_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","volume":"60","author":"RR Ji","year":"2009","unstructured":"Ji RR, Gereau RWt, Malcangio M, Strichartz GR (2009) MAP kinase and pain. Brain Res Rev 60:135\u2013148","journal-title":"Brain Res Rev"},{"key":"2454_CR60","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.1523\/JNEUROSCI.2396-04.2004","volume":"24","author":"Y Kawasaki","year":"2004","unstructured":"Kawasaki Y, Kohno T, Zhuang ZY, Brenner GJ, Wang H, Van Der Meer C et al (2004) Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci 24:8310\u20138321","journal-title":"J Neurosci"},{"key":"2454_CR61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1744-8069-3-33","volume":"3","author":"RR Ji","year":"2007","unstructured":"Ji RR, Suter MR (2007) p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 3:33","journal-title":"Mol Pain"},{"key":"2454_CR62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neulet.2008.03.017","volume":"437","author":"YJ Gao","year":"2008","unstructured":"Gao YJ, Ji RR (2008) Activation of JNK pathway in persistent pain. Neurosci Lett 437:180\u2013183","journal-title":"Neurosci Lett"},{"key":"2454_CR63","doi-asserted-by":"publisher","first-page":"992","DOI":"10.24976\/Discov.Med.202436184.92","volume":"36","author":"XL Zheng","year":"2024","unstructured":"Zheng XL, Chen L, Fan CL, Xiao SJ, Chen SB, Yang FM (2024) Hyperbaric Lidocaine Aggravates Diabetic Neuropathic Pain by Targeting p38 MAPK\/ERK and PINK1\/Parkin-Mediated Mitophagy Signaling Pathway. Discov Med 36:992\u20131001","journal-title":"Discov Med"},{"key":"2454_CR64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/1568010043343804","volume":"3","author":"RR Ji","year":"2004","unstructured":"Ji RR (2004) Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. Curr Drug Targets Inflamm Allergy 3:299\u2013303","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"2454_CR65","doi-asserted-by":"publisher","first-page":"115043","DOI":"10.1016\/j.expneurol.2024.115043","volume":"383","author":"FX Lin","year":"2025","unstructured":"Lin FX, Gu HY, He W (2025) MAPK signaling pathway in spinal cord injury: Mechanisms and therapeutic potential. Exp Neurol 383:115043","journal-title":"Exp Neurol"},{"key":"2454_CR66","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/14728222.2025.2489540","volume":"29","author":"D Zimmermann","year":"2025","unstructured":"Zimmermann D, Kress M, Nagy I (2025) Established and emerging roles of protein kinases in regulating primary sensory neurons in injury-and inflammation-associated pain. Expert Opin Ther Targets 29:267\u2013280","journal-title":"Expert Opin Ther Targets"},{"key":"2454_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11064-023-04025-4","volume":"49","author":"MJ Wang","year":"2024","unstructured":"Wang MJ, Jing XY, Wang YZ, Yang BR, Lu Q, Hu H et al (2024) Exercise, Spinal Microglia and Neuropathic Pain: Potential Molecular Mechanisms. Neurochem Res 49:29\u201337","journal-title":"Neurochem Res"},{"key":"2454_CR68","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1523\/JNEUROSCI.5290-05.2006","volume":"26","author":"ZY Zhuang","year":"2006","unstructured":"Zhuang ZY, Wen YR, Zhang DR, Borsello T, Bonny C, Strichartz GR et al (2006) A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 26:3551\u20133560","journal-title":"J Neurosci"},{"key":"2454_CR69","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pain.2004.12.022","volume":"114","author":"ZY Zhuang","year":"2005","unstructured":"Zhuang ZY, Gerner P, Woolf CJ, Ji RR (2005) ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114:149\u2013159","journal-title":"Pain"},{"key":"2454_CR70","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1523\/JNEUROSCI.23-03-01026.2003","volume":"23","author":"ED Milligan","year":"2003","unstructured":"Milligan ED, Twining C, Chacur M, Biedenkapp J, O\u2019Connor K, Poole S et al (2003) Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23:1026\u20131040","journal-title":"J Neurosci"},{"key":"2454_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0896-6273(02)00908-X","volume":"36","author":"RR Ji","year":"2002","unstructured":"Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36:57\u201368","journal-title":"Neuron"},{"key":"2454_CR72","doi-asserted-by":"crossref","unstructured":"Ji RR, Strichartz G (2004) Cell signaling and the genesis of neuropathic pain. Sci STKE 2004:reE14","DOI":"10.1126\/stke.2522004re14"},{"key":"2454_CR73","doi-asserted-by":"crossref","unstructured":"Li CL, Yang R, Sun Y, Feng Y, Song YB (2021) N58A exerts analgesic effect on trigeminal neuralgia by regulating the MAPK pathway and tetrodotoxin-resistant sodium channel. Toxins (Basel) 13","DOI":"10.3390\/toxins13050357"},{"key":"2454_CR74","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1523\/JNEUROSCI.4403-07.2008","volume":"28","author":"A Hudmon","year":"2008","unstructured":"Hudmon A, Choi JS, Tyrrell L, Black JA, Rush AM, Waxman SG et al (2008) Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci 28:3190\u20133201","journal-title":"J Neurosci"},{"key":"2454_CR75","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1523\/JNEUROSCI.0541-05.2005","volume":"25","author":"EK Wittmack","year":"2005","unstructured":"Wittmack EK, Rush AM, Hudmon A, Waxman SG, Dib-Hajj SD (2005) Voltage-gated sodium channel Nav1.6 is modulated by p38 mitogen-activated protein kinase. J Neurosci 25:6621\u20136630","journal-title":"J Neurosci"},{"key":"2454_CR76","doi-asserted-by":"publisher","first-page":"14062","DOI":"10.1523\/JNEUROSCI.3795-08.2008","volume":"28","author":"AM Binshtok","year":"2008","unstructured":"Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L et al (2008) Nociceptors are interleukin-1beta sensors. J Neurosci 28:14062\u201314073","journal-title":"J Neurosci"},{"key":"2454_CR77","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1152\/jn.00652.2014","volume":"113","author":"S Gudes","year":"2015","unstructured":"Gudes S, Barkai O, Caspi Y, Katz B, Lev S, Binshtok AM (2015) The role of slow and persistent TTX-resistant sodium currents in acute tumor necrosis factor-\u03b1-mediated increase in nociceptors excitability. J Neurophysiol 113:601\u2013619","journal-title":"J Neurophysiol"},{"key":"2454_CR78","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/14728222.2020.1815191","volume":"24","author":"M Souza","year":"2020","unstructured":"Souza M, de Araujo D, Nassini R, Geppetti P, De Logu F (2020) TRPThird, as a therapeutic target for nociceptive pain. Expert Opin Ther Targets 24:997\u20131008","journal-title":"Expert Opin Ther Targets"},{"key":"2454_CR79","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","volume":"19","author":"P Baral","year":"2019","unstructured":"Baral P, Udit S, Chiu IM (2019) Pain and immunity: implications for host defence. Nat Rev Immunol 19:433\u2013447","journal-title":"Nat Rev Immunol"},{"key":"2454_CR80","doi-asserted-by":"publisher","first-page":"113685","DOI":"10.1016\/j.celrep.2024.113685","volume":"43","author":"S Tyagi","year":"2024","unstructured":"Tyagi S, Higerd-Rusli GP, Ghovanloo MR, Dib-Hajj F, Zhao P, Liu S et al (2024) Compartment-specific regulation of Na(V)1.7 in sensory neurons after acute exposure to TNF-\u03b1. Cell Rep 43:113685","journal-title":"Cell Rep"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02454-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:02:35Z","timestamp":1786359755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02454-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2454"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02454-4","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experimental procedures were reviewed and approved by the Animal Ethics Committee of the School of Basic Medical Sciences, Lanzhou University (Approval No. Lzujcyxy20251004). All experiments were conducted in accordance with the approved protocol and the institutional guidelines for the care and use of laboratory animals.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"202"}}